John Turchi receives $2.9 million from NCI to improve effectiveness of lung cancer radiation therapy

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

John Turchi, a researcher at Indiana University Melvin and Bren Simon Comprehensive Cancer Center, has been awarded a five-year, $2.9 million grant from NCI to develop a drug that could make radiation therapy far more effective.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

The day before health economist Jay Bhattacharya stepped into his new role as NIH director, he sent a document to his employees outlining his top five priorities for the department, which included “reproducibility” and “transparency,” two themes he discussed at his confirmation hearings (The Cancer Letter, March 7, 2025).

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login